Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Prostatic Neoplasms 9 Colorectal Neoplasms 7 Ovarian Neoplasms 5 Endometrial Neoplasms 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Pancreatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Wilms Tumor 2 Urogenital Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplastic Syndromes, Hereditary 2 Neoplasms, Unknown Primary 2 Neoplasm Metastasis 2 Melanoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Leukemia 2 Kidney Neoplasms 2 Hereditary Breast and Ovarian Cancer Syndrome 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Glioma 2

Interventions

abemaciclib 1 Trastuzumab 1 Tablets 1 Genetic Testing 1 Fulvestrant 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hormone Receptor Positive Breast Cancer × Genetic Testing × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡